Skip to main content
VulnerabilityPublished

CVE-2026-105920: Kusalkasilva Learning-Management-System · Injection

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-105920· Medium 6.9

Public exploit available · CVSS 6.9 Medium.

Data as of 20 Nov 2026, 17:34 UTC

CVSS 4.0 base score
6.9Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 18% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 6 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: evidence found.

    CVSS exploit maturity: proof of concept public

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
KusalkasilvaLearning-Management-SystemAffected
  • =ffeb873f8803f1e9664384ff75000c7da45466d2
Fixed in–

AI-suggested

Users should monitor the vendor's communications for updates. Until a fix is released, consider applying application-layer protections such as web application firewalls (WAF) to detect and block SQL injection attempts targeting the student_signup.php endpoint.

Description

A SQL injection vulnerability exists in the Kusalkasilva Learning-Management-System in the student_signup.php file's Student Registration Endpoint. This vulnerability allows remote attackers to manipulate SQL queries, potentially impacting confidentiality, integrity, and availability. The vulnerability has been publicly disclosed, but no official response or patch from the project is available yet. The product uses a rolling release model, so specific affected versions are not identified. The CVSS score is 7.3, indicating a medium severity risk.

References

Community reviews

Loading reviews…